Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1998-12-3
pubmed:abstractText
To determine whether sulfasalazine is better than placebo in slowing disability progression in MS.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0028-3878
pubmed:author
pubmed:issnType
Print
pubmed:volume
51
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1342-52
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9818858-Adult, pubmed-meshheading:9818858-Anti-Inflammatory Agents, Non-Steroidal, pubmed-meshheading:9818858-Brain, pubmed-meshheading:9818858-Canada, pubmed-meshheading:9818858-Disabled Persons, pubmed-meshheading:9818858-Disease Progression, pubmed-meshheading:9818858-Double-Blind Method, pubmed-meshheading:9818858-Female, pubmed-meshheading:9818858-Follow-Up Studies, pubmed-meshheading:9818858-Humans, pubmed-meshheading:9818858-Magnetic Resonance Imaging, pubmed-meshheading:9818858-Male, pubmed-meshheading:9818858-Minnesota, pubmed-meshheading:9818858-Multiple Sclerosis, pubmed-meshheading:9818858-Placebos, pubmed-meshheading:9818858-Recurrence, pubmed-meshheading:9818858-Sulfasalazine, pubmed-meshheading:9818858-Survival Analysis, pubmed-meshheading:9818858-Time Factors
pubmed:year
1998
pubmed:articleTitle
The Mayo Clinic-Canadian Cooperative trial of sulfasalazine in active multiple sclerosis.
pubmed:affiliation
Mayo Clinic/Mayo Foundation, Rochester, MN 55905, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase III